News Home

Should You Sell Regeneron Pharmaceuticals Inc (REGN) in Biotechnology Industry?

Monday, October 11, 2021 01:02 PM | InvestorsObserver Analysts
Should You Sell Regeneron Pharmaceuticals Inc (REGN) in Biotechnology Industry?

Regeneron Pharmaceuticals Inc (REGN) is around the top of the Biotechnology industry according to InvestorsObserver. REGN received an overall rating of 59, which means that it scores higher than 59 percent of all stocks. Regeneron Pharmaceuticals Inc also achieved a score of 85 in the Biotechnology industry, putting it above 85 percent of Biotechnology stocks. Biotechnology is ranked 81 out of the 148 industries.

Overall Score - 59
REGN has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on REGN!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Regeneron Pharmaceuticals Inc Stock Today?

Regeneron Pharmaceuticals Inc (REGN) stock is trading at $550.56 as of 12:49 PM on Monday, Oct 11, a gain of $0.54, or 0.1% from the previous closing price of $550.02. Volume today is low. So far 236,333 shares have traded compared to average volume of 746,194 shares. The stock has traded between $547.39 and $557.87 so far today. Click Here to get the full Stock Report for Regeneron Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App